Menu Search
Equities

Koa Shoji Holdings Co Ltd

9273:TYO

Koa Shoji Holdings Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)595.00
  • Today's Change2.00 / 0.34%
  • Shares traded10.00k
  • 1 Year change-22.83%
  • Beta0.9298
Data delayed at least 20 minutes, as of Nov 13 2024 00:19 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Koa Shoji Holdings Co Ltd had revenues remain flat at 22.05bn, though the company grew net income 9.64% from 2.69bn to 2.95bn. A reduction in the cost of goods sold as a percentage of sales from 70.78% to 70.00% was a component in the net income growth despite flat revenues.
Gross margin30.81%
Net profit margin13.98%
Operating margin20.20%
Return on assets9.84%
Return on equity12.84%
Return on investment11.79%
More ▼

Cash flow in JPYView more

In 2024, Koa Shoji Holdings Co Ltd increased its cash reserves by 31.49%, or 3.16bn. The company earned 3.83bn from its operations for a Cash Flow Margin of 17.31%. In addition the company generated 795.25m cash from financing while 1.47bn was spent on investing.
Cash flow per share67.88
Price/Cash flow per share9.33
Book value per share600.03
Tangible book value per share599.80
More ▼

Balance sheet in JPYView more

Koa Shoji Holdings Co Ltd appears to have a strong balance sheet and has grown its cash reserves consistently over the last four years to total 13.95bn. In fact, 0.55% of the value of Koa Shoji Holdings Co Ltd shares can be attributed to this cash.
Current ratio5.16
Quick ratio4.56
Total debt/total equity0.108
Total debt/total capital0.0975
More ▼

Growth rates in JPY

Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked below the industry average relative to its peers.
Div yield(5 year avg)1.67%
Div growth rate (5 year)16.72%
Payout ratio (TTM)18.35%
EPS growth(5 years)35.05
EPS (TTM) vs
TTM 1 year ago		3.14
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.